243 related articles for article (PubMed ID: 26565015)
1. When sepsis persists: a review of MRSA bacteraemia salvage therapy.
Kullar R; Sakoulas G; Deresinski S; van Hal SJ
J Antimicrob Chemother; 2016 Mar; 71(3):576-86. PubMed ID: 26565015
[TBL] [Abstract][Full Text] [Related]
2. Treatment strategies for persistent methicillin-resistant Staphylococcus aureus bacteraemia.
Lewis PO; Heil EL; Covert KL; Cluck DB
J Clin Pharm Ther; 2018 Oct; 43(5):614-625. PubMed ID: 30003555
[TBL] [Abstract][Full Text] [Related]
3. Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy.
Ho TT; Cadena J; Childs LM; Gonzalez-Velez M; Lewis JS
J Antimicrob Chemother; 2012 May; 67(5):1267-70. PubMed ID: 22311935
[TBL] [Abstract][Full Text] [Related]
4. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
Jang HC; Kim SH; Kim KH; Kim CJ; Lee S; Song KH; Jeon JH; Park WB; Kim HB; Park SW; Kim NJ; Kim EC; Oh MD; Choe KW
Clin Infect Dis; 2009 Aug; 49(3):395-401. PubMed ID: 19569970
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial.
del Río A; Gasch O; Moreno A; Peña C; Cuquet J; Soy D; Mestres CA; Suárez C; Pare JC; Tubau F; Garcia de la Mària C; Marco F; Carratalà J; Gatell JM; Gudiol F; Miró JM;
Clin Infect Dis; 2014 Oct; 59(8):1105-12. PubMed ID: 25048851
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.
Kufel WD; Parsels KA; Blaine BE; Steele JM; Mahapatra R; Paolino KM; Thomas SJ
Pharmacotherapy; 2023 Jan; 43(1):15-23. PubMed ID: 36371648
[TBL] [Abstract][Full Text] [Related]
7. Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia.
Burnett YJ; Echevarria K; Traugott KA
Ann Pharmacother; 2016 Dec; 50(12):1051-1059. PubMed ID: 27520326
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia.
Barber KE; Rybak MJ; Sakoulas G
J Antimicrob Chemother; 2015 Jan; 70(1):311-3. PubMed ID: 25125677
[No Abstract] [Full Text] [Related]
9. Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: case series and review of the literature.
Polenakovik HM; Pleiman CM
Int J Antimicrob Agents; 2013 Nov; 42(5):450-5. PubMed ID: 23993067
[TBL] [Abstract][Full Text] [Related]
10. Telavancin for refractory methicillin-resistant Staphylococcus aureus bacteremia and infective endocarditis.
Ruggero MA; Peaper DR; Topal JE
Infect Dis (Lond); 2015 Jun; 47(6):379-84. PubMed ID: 25746601
[TBL] [Abstract][Full Text] [Related]
11. Ceftaroline for the treatment of methicillin-resistant
White BP; Barber KE; Stover KR
Am J Health Syst Pharm; 2017 Feb; 74(4):201-208. PubMed ID: 28179245
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.
Park HJ; Kim SH; Kim MJ; Lee YM; Park SY; Moon SM; Park KH; Chong YP; Lee SO; Choi SH; Woo JH; Kim YS
J Infect; 2012 Dec; 65(6):505-12. PubMed ID: 22902942
[TBL] [Abstract][Full Text] [Related]
13. Ceftaroline fosamil salvage therapy: an option for reduced-vancomycin-susceptible MRSA bacteraemia.
Espedido BA; Jensen SO; van Hal SJ
J Antimicrob Chemother; 2015 Mar; 70(3):797-801. PubMed ID: 25406295
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Daptomycin Plus Ceftaroline Versus Alternative Therapy for Persistent Methicillin-resistant Staphylococcus aureus (MRSA) Bacteraemia.
Patel D; Brown ML; Edwards S; Oster RA; Stripling J
Int J Antimicrob Agents; 2023 Mar; 61(3):106735. PubMed ID: 36690124
[TBL] [Abstract][Full Text] [Related]
15. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.
Murray KP; Zhao JJ; Davis SL; Kullar R; Kaye KS; Lephart P; Rybak MJ
Clin Infect Dis; 2013 Jun; 56(11):1562-9. PubMed ID: 23449272
[TBL] [Abstract][Full Text] [Related]
16. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
Mohan SS; McDermott BP; Cunha BA
Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
[TBL] [Abstract][Full Text] [Related]
17. Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.
Yoon YK; Kim JY; Park DW; Sohn JW; Kim MJ
J Antimicrob Chemother; 2010 May; 65(5):1015-8. PubMed ID: 20200036
[TBL] [Abstract][Full Text] [Related]
18. Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial.
Shaw E; Miró JM; Puig-Asensio M; Pigrau C; Barcenilla F; Murillas J; Garcia-Pardo G; Espejo E; Padilla B; Garcia-Reyne A; Pasquau J; Rodriguez-Baño J; López-Contreras J; Montero M; de la Calle C; Pintado V; Calbo E; Gasch O; Montejo M; Salavert M; Garcia-Pais MJ; Carratalà J; Pujol M; ; ;
BMJ Open; 2015 Mar; 5(3):e006723. PubMed ID: 25762232
[TBL] [Abstract][Full Text] [Related]
19. Daptomycin in combination with other antibiotics for the treatment of complicated methicillin-resistant Staphylococcus aureus bacteremia.
Dhand A; Sakoulas G
Clin Ther; 2014 Oct; 36(10):1303-16. PubMed ID: 25444563
[TBL] [Abstract][Full Text] [Related]
20. Fatal bacteraemia and infective endocarditis due to meticillin-resistant Staphylococcus aureus (MRSA) with rapid emergence of rifampicin resistance during vancomycin/rifampicin combination treatment.
Liu WL; Hung YL; Lin SH; Lee PI; Hsueh PR
Int J Antimicrob Agents; 2010 Jun; 35(6):615-6. PubMed ID: 20236804
[No Abstract] [Full Text] [Related]
[Next] [New Search]